← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Ortholevo, Inc.
Lynnfield, MA
$3,386,154
Total funding
3
Grants
Funding over time
peak $1.5M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,710,707 · 2
DOD$675,447 · 1
By mechanism
R44$1,701,141 · 1
SB1$1,009,566 · 1
—$675,447 · 1
Investigators at Ortholevo, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Enabling Studies for the Treatment of Frozen Shoulder Using Relaxin$914,843
R44 · FY2022 · AR
Enabling Studies for the Treatment of Frozen Shoulder Using Relaxin$786,298
R44 · FY2021 · AR
A NOVEL OFFICE-BASED INJECTABLE TO TREAT DUCHENNE-RELATED FIBROSIS$675,447
· FY2021 · Defense Health Agency
Late Stage Development of Sustained-release Relaxin for Treating Joint Contracture$504,965
SB1 · FY2024 · AR
Late Stage Development of Sustained-release Relaxin for Treating Joint Contracture$504,601
SB1 · FY2025 · AR